Suppr超能文献

美国国家标准与技术研究院(NIST)参考抗体RM 8671的Fab片段的生物物理特性及结构

Biophysical characterization and structure of the Fab fragment from the NIST reference antibody, RM 8671.

作者信息

Karageorgos Ioannis, Gallagher Elyssia S, Galvin Connor, Gallagher D Travis, Hudgens Jeffrey W

机构信息

Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD 20850, USA; Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850, USA.

Biomolecular Measurement Division, National Institute of Standards & Technology, Rockville, MD 20850, USA; Institute for Bioscience and Biotechnology Research, 9600 Gudelsky Drive, Rockville, MD 20850, USA.

出版信息

Biologicals. 2017 Nov;50:27-34. doi: 10.1016/j.biologicals.2017.09.005. Epub 2017 Sep 29.

Abstract

Monoclonal antibody pharmaceuticals are the fastest-growing class of therapeutics, with a wide range of clinical applications. To assure their safety, these protein drugs must demonstrate highly consistent purity and stability. Key to these objectives is higher order structure measurements validated by calibration to reference materials. We describe preparation, characterization, and crystal structure of the Fab fragment prepared from the NIST Reference Antibody RM 8671 (NISTmAb). NISTmAb is a humanized IgG1κ antibody, produced in murine cell culture and purified by standard biopharmaceutical production methods, developed at the National Institute of Standards and Technology (NIST) to serve as a reference material. The Fab fragment was derived from NISTmAb through papain cleavage followed by protein A based purification. The purified Fab fragment was characterized by SDS-PAGE, capillary gel electrophoresis, multi-angle light scattering, size exclusion chromatography, mass spectrometry, and x-ray crystallography. The crystal structure at 0.2 nm resolution includes four independent Fab molecules with complete light chains and heavy chains through Cys 223, enabling assessment of conformational variability and providing a well-characterized reference structure for research and engineering applications. This nonproprietary, publically available reference material of known higher-order structure can support metrology in biopharmaceutical applications, and it is a suitable platform for validation of molecular modeling studies.

摘要

单克隆抗体药物是增长最快的一类治疗药物,具有广泛的临床应用。为确保其安全性,这些蛋白质药物必须表现出高度一致的纯度和稳定性。实现这些目标的关键是通过与参考物质校准来验证的高阶结构测量。我们描述了从美国国家标准与技术研究院(NIST)参考抗体RM 8671(NISTmAb)制备的Fab片段的制备、表征和晶体结构。NISTmAb是一种人源化IgG1κ抗体,在鼠细胞培养物中产生,并通过标准生物制药生产方法纯化,由美国国家标准与技术研究院(NIST)开发用作参考物质。Fab片段是通过木瓜蛋白酶切割NISTmAb,然后基于蛋白A进行纯化得到的。纯化后的Fab片段通过SDS-PAGE、毛细管凝胶电泳、多角度光散射、尺寸排阻色谱、质谱和X射线晶体学进行表征。分辨率为0.2nm的晶体结构包括四个独立的Fab分子,其轻链和重链通过Cys 223完整,能够评估构象变异性,并为研究和工程应用提供一个特征明确的参考结构。这种具有已知高阶结构的非专利、公开可用的参考物质可支持生物制药应用中的计量学,并且是验证分子建模研究的合适平台。

相似文献

1
Biophysical characterization and structure of the Fab fragment from the NIST reference antibody, RM 8671.
Biologicals. 2017 Nov;50:27-34. doi: 10.1016/j.biologicals.2017.09.005. Epub 2017 Sep 29.
2
Development of orthogonal NISTmAb size heterogeneity control methods.
Anal Bioanal Chem. 2018 Mar;410(8):2095-2110. doi: 10.1007/s00216-017-0819-3. Epub 2018 Feb 10.
3
Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
Hum Vaccin Immunother. 2015;11(2):458-67. doi: 10.4161/21645515.2014.990856.
4
Qualification of NISTmAb charge heterogeneity control assays.
Anal Bioanal Chem. 2018 Mar;410(8):2079-2093. doi: 10.1007/s00216-017-0816-6. Epub 2018 Feb 9.
5
Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulation : Part I: Dilute protein solutions.
Anal Bioanal Chem. 2018 Mar;410(8):2141-2159. doi: 10.1007/s00216-018-0868-2. Epub 2018 Feb 9.
6
The NISTmAb Reference Material 8671 value assignment, homogeneity, and stability.
Anal Bioanal Chem. 2018 Mar;410(8):2127-2139. doi: 10.1007/s00216-017-0800-1. Epub 2018 Feb 7.
7
Isolation and characterization of a monoclonal antibody containing an extra heavy-light chain Fab arm.
MAbs. 2018 Apr;10(3):346-353. doi: 10.1080/19420862.2018.1438795. Epub 2018 Mar 20.
10
The NISTmAb Reference Material 8671 lifecycle management and quality plan.
Anal Bioanal Chem. 2018 Mar;410(8):2067-2078. doi: 10.1007/s00216-017-0844-2. Epub 2018 Feb 12.

引用本文的文献

1
A novel serum stability assay for antibody therapeutics incorporating internal standards.
MAbs. 2025 Dec;17(1):2479529. doi: 10.1080/19420862.2025.2479529. Epub 2025 Mar 17.
2
Systematic Fe(II)-EDTA Method of Dose-Dependent Hydroxyl Radical Generation for Protein Oxidative Footprinting.
Anal Chem. 2023 Dec 19;95(50):18316-18325. doi: 10.1021/acs.analchem.3c02319. Epub 2023 Dec 4.
3
Effects of glycans and hinge on dynamics in the IgG1 Fc.
J Biomol Struct Dyn. 2024;42(22):12571-12579. doi: 10.1080/07391102.2023.2270749. Epub 2023 Oct 28.
4
Atomic Model Structure of the NIST Monoclonal Antibody (NISTmAb) Reference Material.
J Res Natl Inst Stand Technol. 2021 Jul 15;126:126012. doi: 10.6028/jres.126.012. eCollection 2021.
5
Dataset from HDX-MS Studies of IgG1 Glycoforms and Their Interactions with the FcγRIa (CD64) Receptor.
J Res Natl Inst Stand Technol. 2021 Jun 17;vol:126010. doi: 10.6028/jres.126.010. eCollection 2021.
6
Backbone and side-chain resonance assignments of the NISTmAb-scFv and antigen-binding study.
Biomol NMR Assign. 2022 Oct;16(2):391-398. doi: 10.1007/s12104-022-10109-z. Epub 2022 Sep 9.
7
Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics.
Front Mol Biosci. 2022 May 5;9:876780. doi: 10.3389/fmolb.2022.876780. eCollection 2022.
8
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) Centroid Data Measured between 3.6 °C and 25.4 °C for the Fab Fragment of NISTmAb.
J Res Natl Inst Stand Technol. 2019 May 2;124:1-7. doi: 10.6028/jres.124.009. eCollection 2019.
9
Site-specific glycan-conjugated NISTmAb antibody drug conjugate mimetics: synthesis, characterization, and utility.
Anal Bioanal Chem. 2021 Aug;413(20):4989-5001. doi: 10.1007/s00216-021-03460-y. Epub 2021 Jul 6.

本文引用的文献

1
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab.
Nat Struct Mol Biol. 2015 Dec;22(12):953-8. doi: 10.1038/nsmb.3129. Epub 2015 Nov 23.
2
Mapping monoclonal antibody structure by 2D 13C NMR at natural abundance.
Anal Chem. 2015 Apr 7;87(7):3556-61. doi: 10.1021/ac504804m. Epub 2015 Mar 9.
3
The therapeutic monoclonal antibody market.
MAbs. 2015;7(1):9-14. doi: 10.4161/19420862.2015.989042.
4
Applications of hydrogen/deuterium exchange MS from 2012 to 2014.
Anal Chem. 2015 Jan 6;87(1):99-118. doi: 10.1021/ac5040242. Epub 2014 Nov 14.
5
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3304-9. doi: 10.1073/pnas.1222845110. Epub 2013 Feb 8.
6
A systematic comparison of free and bound antibodies reveals binding-related conformational changes.
J Immunol. 2012 Nov 15;189(10):4890-9. doi: 10.4049/jimmunol.1201493. Epub 2012 Oct 12.
8
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.
Nat Rev Drug Discov. 2012 Jun 29;11(7):527-40. doi: 10.1038/nrd3746.
10
Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus.
J Mol Biol. 2011 Jun 24;409(5):853-66. doi: 10.1016/j.jmb.2011.04.044. Epub 2011 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验